ew-a-401 dna plasmid vector
Gene therapyexperimental
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Mar 27, 2004 (NCT00080392)
Timeline
2000s
- Jan 1, 2004
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Vascular endothelial growth factor ASupplementation
VEGFA supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ew-a-401 dna plasmid vector
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00080392 | Phase 1 | Mar 27, 2004 | National Heart, Lung, and Blood Institute (NHLBI) |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Heart, Lung, and Blood Institute (NHLBI) | Government | 1 | 1 | 1 | 2004 |
1 organizations
Page 1 / 1